Literature DB >> 30509394

Acute and Chronic Suppurative Osteomyelitis of the Jaws: A 10-Year Review and Assessment of Treatment Outcome.

Tyler H Haeffs1, Christopher A Scott1, Tiffany H Campbell2, Youbai Chen3, Meredith August4.   

Abstract

PURPOSE: To review cases of suppurative osteomyelitis of the jaws treated at the Massachusetts General Hospital (Boston, MA) over a 10-year period, evaluate specifics of disease presentation, and answer the clinical question: are there identifiable variables associated with treatment outcome?
MATERIALS AND METHODS: A retrospective cohort study was completed using patients treated for suppurative osteomyelitis of the jaws at the Massachusetts General Hospital from April 2006 to October 2016. Inclusion criteria were a diagnosis of suppurative osteomyelitis of the jaw, age older than 18 years, and complete medical records. Patients with nonsuppurative disease, radiation history, or antiresorptive exposure were excluded. Candidate variables included demographic information, medical and dental history, presenting signs and symptoms, and radiologic and laboratory findings. The outcome variable was successful treatment, defined as resolution of symptoms and radiographic evidence of healing after initial treatment. Appropriate statistical analyses were performed with significance set a P value less than .05.
RESULTS: Forty-two patients met the inclusion criteria. Mean age was 53 years (range, 20 to 80 yr) and 26 were women (62%). Common comorbidities included cardiovascular disease (52%), tobacco use (45%), and psychiatric disorders (45%). Pain (90%), swelling (86%), and neurosensory change (50%) were the most common findings. Common microbacterial isolates included Streptococcus milleri (74%) and coagulase-negative Staphylococcus species (43%), which showed marked antibiotic resistance. Surgical debridement was the most common intervention (93%). Successful treatment was found in 86%. Of 6 persistent cases, 4 resolved with a second debridement and continued antibiotics and 2 required resection. Increased white blood cell (WBC) count at presentation (P = .005) and associated psychiatric diagnoses (P = .037) were statistically associated with unsuccessful initial treatment.
CONCLUSION: The results of this study indicate that antibiotic resistance is commonly encountered in this patient population, although it was not associated with unsuccessful outcome. Patients presenting with increased WBC count and concurrent psychiatric comorbidities required protracted treatment.
Copyright © 2018 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30509394     DOI: 10.1016/j.joms.2018.05.040

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  4 in total

1.  Development of osteomyelitis following dental abscesses-influence of therapy and comorbidities.

Authors:  Julius Moratin; Christian Freudlsperger; Karl Metzger; Caroline Braß; Moritz Berger; Michael Engel; Jürgen Hoffmann; Oliver Ristow
Journal:  Clin Oral Investig       Date:  2020-07-07       Impact factor: 3.573

Review 2.  Coagulase-negative staphylococci (CoNS) as a significant etiological factor of laryngological infections: a review.

Authors:  Michał Michalik; Alfred Samet; Adrianna Podbielska-Kubera; Vincenzo Savini; Jacek Międzobrodzki; Maja Kosecka-Strojek
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-06-04       Impact factor: 3.944

3.  Prophylactic Effects of NFκB Essential Modulator-Binding Domain Peptides on Bone Infection: An Experimental Study in a Rabbit Model.

Authors:  Wen-Jiao Wu; Chang-Liang Xia; Shuan-Ji Ou; Yang Yang; Xiao-Zhong Zhou; Yun-Fei Ma; Yi-Long Hou; Fa-Zheng Wang; Qing-Po Yang; Yong Qi; Chang-Peng Xu
Journal:  J Inflamm Res       Date:  2022-04-28

4.  Treatment and Clinical Outcomes of Osteoarticular Infections Among Pediatrics Admitted to Jimma University Medical Center, Ethiopia: A Prospective Observational Study.

Authors:  Mekonnen Damessa Mamo; Fekede Bekele Daba; Mohammed Beshir; Korinan Fanta
Journal:  Infect Drug Resist       Date:  2021-07-27       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.